N Stuart

4.3k total citations · 1 hit paper
36 papers, 1.9k citations indexed

About

N Stuart is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, N Stuart has authored 36 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in N Stuart's work include Lymphoma Diagnosis and Treatment (5 papers), Estrogen and related hormone effects (4 papers) and Cancer survivorship and care (4 papers). N Stuart is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Estrogen and related hormone effects (4 papers) and Cancer survivorship and care (4 papers). N Stuart collaborates with scholars based in United Kingdom, United States and Australia. N Stuart's co-authors include Adrian L. Harris, Michael J. Greenall, K Smith, E Horak, S LeJeune, Russell Leek, Kasia Stepniewska, Richard D Neal, Clare Wilkinson and Ruth Lewis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

N Stuart

36 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

1992 697 citations E Horak, Russell Leek et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
N Stuart United Kingdom	18	781	744	503	240	232	36	1.9k
Alberto Costa Italy	27	1.0k 1.3×	1.1k 1.4×	496 1.0×	177 0.7×	291 1.3×	68	2.6k
Karina Vera United States	10	816 1.0×	723 1.0×	287 0.6×	111 0.5×	762 3.3×	17	1.7k
Alan P. Lyss United States	27	374 0.5×	1.2k 1.7×	327 0.7×	223 0.9×	879 3.8×	66	2.7k
Khalil Zaman Switzerland	28	483 0.6×	991 1.3×	476 0.9×	83 0.3×	379 1.6×	100	2.0k
Monique M.E.M. Bos Netherlands	19	527 0.7×	1.1k 1.5×	407 0.8×	107 0.4×	667 2.9×	36	2.1k
Patricia Stephenson United States	21	381 0.5×	693 0.9×	261 0.5×	129 0.5×	880 3.8×	48	1.8k
Helle Pappot Denmark	25	369 0.5×	1.2k 1.6×	683 1.4×	176 0.7×	467 2.0×	155	2.3k
Ged Byrne United Kingdom	16	547 0.7×	356 0.5×	278 0.6×	73 0.3×	121 0.5×	47	1.1k
Pamela Kearns United Kingdom	26	830 1.1×	837 1.1×	271 0.5×	470 2.0×	168 0.7×	116	2.3k
Bart C. Kuenen Netherlands	17	511 0.7×	519 0.7×	176 0.3×	70 0.3×	264 1.1×	31	1.2k

Countries citing papers authored by N Stuart

Since Specialization

Citations

This map shows the geographic impact of N Stuart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N Stuart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N Stuart more than expected).

Fields of papers citing papers by N Stuart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N Stuart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N Stuart. The network helps show where N Stuart may publish in the future.

Co-authorship network of co-authors of N Stuart

This figure shows the co-authorship network connecting the top 25 collaborators of N Stuart. A scholar is included among the top collaborators of N Stuart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N Stuart. N Stuart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ford, Elizabeth, Valerie Jenkins, Lesley Fallowfield, et al.. (2011). Clinicians’ attitudes towards clinical trials of cancer therapy. British Journal of Cancer. 104(10). 1535–1543. 36 indexed citations

Fowell, Andrew & N Stuart. (2011). Emergencies in palliative medicine. Medicine. 39(11). 660–663. 1 indexed citations

Lewis, Ruth, Richard D Neal, Nefyn Williams, et al.. (2009). Nurse‐led vs. conventional physician‐led follow‐up for patients with cancer: systematic review. Journal of Advanced Nursing. 65(4). 706–723. 139 indexed citations

Lewis, Ruth, Richard D Neal, Maggie Hendry, et al.. (2009). Patients' and healthcare professionals' views of cancer follow-up: systematic review. British Journal of General Practice. 59(564). e248–e259. 114 indexed citations

Stuart, N, et al.. (2007). Analysis of a panel of antibodies to APC reveals consistent activity towards an unidentified protein. British Journal of Cancer. 97(3). 384–390. 10 indexed citations

Neal, Richard D, N Stuart, & Clare Wilkinson. (2005). Testicular cancer: seminoma.. PubMed. 2007(14). 1119–34. 12 indexed citations

Lind, M., C. C. Vernon, Deborah Cruickshank, et al.. (2002). The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. British Journal of Cancer. 86(8). 1243–1249. 91 indexed citations

Bailey, N P, N Stuart, E.M. Bessell, et al.. (1998). Five-year follow-up of a prospective randomised multi-centre trial of weekly chemotherapy (CAPOMEt) versus cyclical chemotherapy (CHOP-Mtx) in the treatment of aggressive non-Hodgkin’s lymphoma. Annals of Oncology. 9(6). 633–638. 8 indexed citations

Stuart, N, Jane Warwick, G. Blackledge, et al.. (1996). A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer. European Journal of Cancer. 32(11). 1888–1892. 29 indexed citations

10.

Philip, P. A., C. Thompson, J. Carmichael, et al.. (1993). A phase I study of the left-shifting agent BW12C79 plus mitomycin C and the effect on the skeletal muscle metabolism using 31P magnetic resonance spectroscopy.. PubMed. 53(23). 5649–53. 6 indexed citations

11.

Kirk, J, S Houlbrook, N Stuart, et al.. (1993). Differential modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites. British Journal of Cancer. 67(6). 1189–1195. 39 indexed citations

12.

Philip, P. A., Daniel Rea, P. Thavasu, et al.. (1993). Phase I Study of Bryostatin 1: Assessment of Interleukin 6 and Tumor Necrosis Factor Induction In Vivo. JNCI Journal of the National Cancer Institute. 85(22). 1812–1818. 151 indexed citations

13.

Harris, Adrian L., et al.. (1993). Angiogenesis in Breast Cancer. Annals of the New York Academy of Sciences. 698(1). 71–84. 16 indexed citations

14.

Kirk, J, S Houlbrook, N Stuart, et al.. (1993). Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolites. European Journal of Cancer. 29(8). 1152–1157. 30 indexed citations

15.

Horak, E, Russell Leek, S LeJeune, et al.. (1992). Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. The Lancet. 340(8828). 1120–1124. 697 indexed citations breakdown →

16.

Child, J. A., D. L. Barnard, L. A. Parapia, et al.. (1991). Twin‐track studies of ifosfamide and mitoxantrone (I‐M) in recurrent high grade non‐hodgkin's lymphoma and hodgkin's disease. Hematological Oncology. 9(4-5). 235–244. 7 indexed citations

17.

Stuart, N, S. M. Crawford, G. Blackledge, et al.. (1989). A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES) ? a new dihydrofolate reductase inhibitor. Cancer Chemotherapy and Pharmacology. 23(5). 308–310. 6 indexed citations

18.

Holgate, C S, Philip Quirke, N Stuart, et al.. (1989). Correlation of morphology, immunophenotype, and flow cytometry with remission induction and survival in high grade non‐Hodgkin's lymphoma. The Journal of Pathology. 158(1). 31–39. 18 indexed citations

19.

Perren, Timothy, N Stuart, D. G. ARKELL, et al.. (1987). Phase II Study of Zoladex Depot in Advanced Prostatic Cancer with Special Reference to Criteria of Response and Survival. British Journal of Urology. 60(5). 436–442. 7 indexed citations

20.

Meanwell, C. A., J. Mould, G. Blackledge, et al.. (1986). Phase II study of ifosfamide in cervical cancer.. PubMed. 70(6). 727–30. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact